Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Burford Capital Ltd (NY: BUR )

13.50 +0.06 (+0.45%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Burford Capital Ltd

< Previous 1 2 3 Next >
BUR Stock Earnings: Burford Capital Reported Results for Q2 2024
Burford Capital just reported results for the second quarter of 2024. 
Via InvestorPlace
Burford Capital Limited Announces Notice of EGM
Via ACCESSWIRE
TeraWulf Posts Weak Results, Joins StoneCo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
BUR Stock Earnings: Burford Capital Reported Results for Q1 2024
Burford Capital just reported results for the first quarter of 2024. 
Via InvestorPlace
Seritage Growth Properties Posts Q1 Loss, Joins Fortrea Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Why the growth investor may take a look at BURFORD CAPITAL LTD (NYSE:BUR).
Why BURFORD CAPITAL LTD (NYSE:BUR) qualifies as a high growth stock. 
Via Chartmill
Burford Capital Ltd. (NYSE: BUR) Records 52-Week High Thursday Morning
Via Investor Brand Network
Burford Capital Ltd. (NYSE: BUR) Near the Top of Equities by Percentage Gain on 3/31
Via Investor Brand Network
Intended Purchases of Burford Capital Ordinary Shares by Employee Benefit Trust
Via ACCESSWIRE
Earnings Scheduled For March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
Burford Capital appointment of Joint Corporate Broker
Via ACCESSWIRE
Burford Capital Releases 2022 GC Survey Results
Via ACCESSWIRE
Maize and Blue Stock Pitch Competition 2024 Showcases Analytical Excellence With Surprising Results, Including A Bearish Call
The Ross School of Business at the University of Michigan hosted the expanded Maize and Blue Stock Pitch Competition on Feb. 
Via Benzinga
Bitcoin ETFs, the Gig Economy, and Robotic Surgery
These investors have a lot to talk about. And Burford Capital CEO Chris Bogart drops in to talk about the world of legal financing, his company's competitive advantages, and a high-stakes case with... 
Via The Motley Fool
Topics ETFs Economy
Exposures Economy
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per... 
Via Benzinga
Coherus BioSciences And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the Dow Jones futures falling around 5 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
AVITA Medical Cuts Revenue Forecast, Joins iQIYI, Trip.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded mostly lower this morning, with the Dow Jones futures falling around 50 points on Tuesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Meta's Plans, Cyberattacks, and the EV Race
And we've got a look at two stocks worth watching: Chevron and Burford Capital. 
Via The Motley Fool
Carlyle Group Stock Scores Rising Relative Strength Rating
Carlyle Group stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 70 to 75. 
Via Investor's Business Daily
Brookfield Asset Mgmt Stock Scores RS Upgrade; Hits Key Threshold
Brookfield Asset Mgmt sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
KKR Stock Rating Jumps. Earnings Due Monday After Blowout Q1.
The number of funds that own KKR stock rose from 1,156 in the March-ended quarter to 1,172 in June, highest in the last four quarters. KKR stock got a rating upgrade Friday. 
Via Investor's Business Daily
Moderating Inflation, a Tasty IPO, Bull Market Talk, and More
We've also got two stocks worth watching: Chevron and Burford Capital. 
Via The Motley Fool
Apellis Pharmaceuticals, VirTra And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy... 
Via Benzinga
Why UiPath Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) rose 38.9% to $5.82 in pre-market trading. ThermoGenesis shares jumped around 99% on Wednesday after the company announced the roll out of ReadyStart... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for another dive into the biggest pre-market stock movers as we go over all the latest news for Thursday morning! 
Via InvestorPlace
LivePerson, Amyris And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Burford Capital Sterling Conversion Rate for 2022 Interim Dividend
Via ACCESSWIRE
Philips, Owens & Minor And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Why Cango Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) rose 43.2% to $0.2097 in pre-market trading after jumping over 16% on Tuesday. Adamis Pharmaceuticals recently announced a review of strategic... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.